These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 22280496)
21. Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Graaf IA; Groothuis GM; Olinga P Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):879-98. PubMed ID: 18028031 [TBL] [Abstract][Full Text] [Related]
22. Alternate strategies to obtain mass balance without the use of radiolabeled compounds: application of quantitative fluorine (19F) nuclear magnetic resonance (NMR) spectroscopy in metabolism studies. Mutlib A; Espina R; Atherton J; Wang J; Talaat R; Scatina J; Chandrasekaran A Chem Res Toxicol; 2012 Mar; 25(3):572-83. PubMed ID: 22292524 [TBL] [Abstract][Full Text] [Related]
23. Drug localization and targeting with receptor microscopic autoradiography. Stumpf WE J Pharmacol Toxicol Methods; 2005; 51(1):25-40. PubMed ID: 15596112 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat. van Beijsterveldt L; Geerts R; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W Arzneimittelforschung; 2004; 54(2):85-94. PubMed ID: 15038457 [TBL] [Abstract][Full Text] [Related]
25. Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics. Landskroner KA; Hess P; Treiber A Xenobiotica; 2011 Aug; 41(8):687-700. PubMed ID: 21486193 [TBL] [Abstract][Full Text] [Related]
26. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. Smith DA; Obach RS Chem Res Toxicol; 2009 Feb; 22(2):267-79. PubMed ID: 19166333 [TBL] [Abstract][Full Text] [Related]
28. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
29. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet? Nassar AE; Talaat RE; Kamel AM Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118 [TBL] [Abstract][Full Text] [Related]
30. Utility of spatially-resolved atmospheric pressure surface sampling and ionization techniques as alternatives to mass spectrometric imaging (MSI) in drug metabolism. Blatherwick EQ; Van Berkel GJ; Pickup K; Johansson MK; Beaudoin ME; Cole RO; Day JM; Iverson S; Wilson ID; Scrivens JH; Weston DJ Xenobiotica; 2011 Aug; 41(8):720-34. PubMed ID: 21671748 [TBL] [Abstract][Full Text] [Related]
31. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
32. Mapping pharmaceuticals in tissues using MALDI imaging mass spectrometry. Hsieh Y; Chen J; Korfmacher WA J Pharmacol Toxicol Methods; 2007; 55(2):193-200. PubMed ID: 16919485 [TBL] [Abstract][Full Text] [Related]
33. Quantification of tissue self-absorption of weak beta-radiation in lyophilized whole-body sections of rats. Klein O; Binder R; Steinke W Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 2):S27-31. PubMed ID: 10806057 [TBL] [Abstract][Full Text] [Related]
34. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept. Reichel A Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839 [TBL] [Abstract][Full Text] [Related]
35. A microplate solid scintillation counter as a radioactivity detector for high performance liquid chromatography in drug metabolism: validation and applications. Bruin GJ; Waldmeier F; Boernsen KO; Pfaar U; Gross G; Zollinger M J Chromatogr A; 2006 Nov; 1133(1-2):184-94. PubMed ID: 16970958 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog. Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917 [TBL] [Abstract][Full Text] [Related]
37. ADME investigations of unnatural peptides: distribution of a 14C-labeled beta 3-octaarginine in rats. Weiss HM; Wirz B; Schweitzer A; Amstutz R; Rodriguez Perez MI; Andres H; Metz Y; Gardiner J; Seebach D Chem Biodivers; 2007 Jul; 4(7):1413-37. PubMed ID: 17638323 [TBL] [Abstract][Full Text] [Related]
38. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. Suzuki YS; Momose Y; Higashi N; Shigematsu A; Park KB; Kim YM; Kim JR; Ryu JM J Nucl Med; 1998 Dec; 39(12):2161-6. PubMed ID: 9867162 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299 [TBL] [Abstract][Full Text] [Related]
40. [The role of ADME evaluation in translation research of innovative drug]. Liu Y; Hong L; Yu LS; Jiang HD; Chen JZ; Meng Q; Chen SQ; Zeng S Yao Xue Xue Bao; 2011 Jan; 46(1):19-29. PubMed ID: 21465804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]